Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi, Antonio Gasbarrini, Luisa Guidi, Rita Monterubbianesi, Annalisa Aratari, Marco Daperno, Livia Biancone, Maria Cappello, Vito Annese, Gabriele Riegler, Ambrogio Orlando, Angelo Viscido, Gianmichele Meucci, Alessandro Lavagna, Raffaello Sostegni, Sara Onali, Claudio Papi, Anna Kohn

Risultato della ricerca: Contributo in rivistaArticolo in rivista

44 Citazioni (Scopus)

Abstract

Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.
Lingua originaleEnglish
pagine (da-a)852-858
Numero di pagine7
RivistaJournal of Crohn's and Colitis
Volume8
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Colectomy
  • Infliximab
  • Ulcerative colitis

Fingerprint Entra nei temi di ricerca di 'Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy'. Insieme formano una fingerprint unica.

Cita questo